Organization Overview
Alternative names
bedaquiline (sirturo) (1 trial)
bifidobacterium animalis (2 trials)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
cinacalcet (sensipar) (1 trial)
cisatracurium (nimbex) (1 trial)
cisplatin (platinol) (12 trials)
clofazimine (lamprene) (1 trial)
crizotinib (xalkori) (1 trial)
cyclophosphamide (cytoxan) (9 trials)
cytarabine (cytosar-u) (6 trials)
doxorubicin (Doxil) (5 trials)
enterococcus faecium (1 trial)
epirubicin (ellence) (3 trials)
esomeprazole (nexium) (3 trials)
etoposide (vepesid) (11 trials)
fosinopril (monopril) (1 trial)
furazolidone (furoxone) (1 trial)
gemcitabine (gemzar) (6 trials)
hydrochlorothiazide (esidrix) (1 trial)
irinotecan (Camptosar) (2 trials)
lenalidomide (revlimid) (2 trials)
lidocaine (xylocaine) (1 trial)
mycophenolate (CellCept) (2 trials)
pegaspargase (oncaspar) (3 trials)
pentazocine (talwin) (1 trial)
polidocanol (asclera) (1 trial)
pomalidomide (pomalyst) (1 trial)
prednisone (meticorten) (7 trials)
propofol (diprivan) (4 trials)
pyrazinamide (Aldinamide) (1 trial)
rituximab (rituxan) (3 trials)
rocuronium (zemuron) (1 trial)
ruxolitinib (jakafi) (1 trial)
sargramostim (leukine) (1 trial)
sevoflurane (ultane) (2 trials)
somatropin (protropin) (2 trials)
tenofovir alafenamide (genvoya) (1 trial)
tetracycline (tetrex) (3 trials)
thalidomide (Thalomid) (2 trials)
thymalfasin (zadaxin) (1 trial)
triptorelin (Trelstar) (2 trials)
vecuronium (norcuron) (1 trial)
vincristine (oncovin) (6 trials)
131i-lipiodol (Lipiodol) (1 trial)
acetazolamide (diamox) (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
alteplase (Activase) (2 trials)
aminophylline (aminophyllin) (1 trial)
asparaginase (elspar) (1 trial)
capecitabine (xeloda) (3 trials)
clopidogrel (plavix) (1 trial)
docetaxel (taxotere) (2 trials)
allogeneic cord blood (1 trial)
allogeneic natural killer cells (1 trial)
autologous mesenchymal stem cell-derived neural progenitors (1 trial)
azacitidine (vidaza) (1 trial)
bacille calmette-guerin (1 trial)
bevacizumab (avastin) (3 trials)
cytokine induced killer cells (1 trial)
fruquintinib (Fruzaqla) (2 trials)
fulvestrant (faslodex) (1 trial)
oxaliplatin (eloxatin) (3 trials)
pembrolizumab (keytruda) (1 trial)
qingre liangkou ningxin fang (1 trial)
autologous dendritic cells electroporated with wt1 mrna (1 trial)
duloxetine (Cymbalta) (1 trial)
immune globulin (human) (Gamastan) (1 trial)
insulin human (humulin) (1 trial)
lutropin alpha (luveris) (1 trial)
Aneurysm (Phase 3)
Brain Diseases (Phase 2)
Brain Ischemia (Phase 2)
Caliciviridae Infections (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Cardiomyopathies (Phase 4)
Cardiomyopathy, Dilated (Phase 4)
Cardiovascular Diseases (Phase 3)
Cerebral Infarction (Phase 4)
Cholangiocarcinoma (Phase 3)
Cognitive Dysfunction (Phase 4)
Critical Illness (Phase 4)
Delayed Emergence from Anesthesia (Phase 4)
Delirium (Phase 4)
Diabetes Mellitus (Phase 1)
Diabetic Nephropathies (Phase 1)
Dwarfism (Phase 3)
Dwarfism, Pituitary (Phase 4)
Endocrine System Diseases (Phase 4)
Enterocolitis (Phase 2)
Enterocolitis, Necrotizing (Phase 2)
Enteropathy-Associated T-Cell Lymphoma (Phase 1)
Enuresis (Phase 4)
Esophageal Neoplasms (Phase 4)
Esophageal Squamous Cell Carcinoma (Phase 3)
Gastroenteritis (Phase 1)
Glomerulonephritis, IGA (Phase 3)
Headache (Phase 3)
Heart Failure (Phase 3)
Heart Failure, Systolic (Phase 3)
Hemorrhage (Phase 3)
Hemorrhoids (Phase 4)
Hepatoblastoma (Phase 4)
Hyperparathyroidism (Phase 4)
Hyperparathyroidism, Secondary (Phase 4)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 3)
Hypoxia (Phase 2)
Hypoxia-Ischemia, Brain (Phase 2)
Immunoblastic Lymphadenopathy (Phase 1)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Intracranial Aneurysm (Phase 3)
Ischemia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 4)
Macular Degeneration (Phase 1)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 1)
Neuralgia (Phase 3)
Neuroblastoma (Phase 4)
Nocturnal Enuresis (Phase 4)
Pancreatic Neoplasms (Phase 2)
Parkinson Disease (Phase 2)
Polyneuropathies (Phase 1)
Post-Dural Puncture Headache (Phase 3)
Postoperative Complications (Phase 4)
Premature Birth (Phase 4)
Recurrence (Phase 2)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 4)
Retinal Diseases (Phase 1)
Retinoblastoma (Phase 4)
Sarcoma, Synovial (Phase 2)
Shock, Cardiogenic (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 4)
Stroke (Phase 4)
Subarachnoid Hemorrhage (Phase 3)
Thrombosis (Phase 3)
Trigeminal Neuralgia (Phase 3)
Urinary Incontinence (Phase 4)
Uterine Cervical Neoplasms (Phase 3)
Wounds and Injuries (Phase 3)